{"id":863571,"date":"2025-06-25T08:44:47","date_gmt":"2025-06-25T12:44:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/"},"modified":"2025-06-25T08:44:47","modified_gmt":"2025-06-25T12:44:47","slug":"immucell-embarks-on-ceo-succession-planning-process","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/","title":{"rendered":"ImmuCell Embarks on CEO Succession Planning Process"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PORTLAND, Maine, June  25, 2025  (GLOBE NEWSWIRE) &#8212; <strong>ImmuCell Corporation (Nasdaq:\u00a0ICCC) <\/strong>(\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today\u00a0announced that it has commenced a search for a successor in the position of President and CEO.<\/p>\n<p>\u201cI turn 65 this fall and have told my fellow Directors that I would like to retire from full-time work by early 2026,\u201d said Michael F. Brigham, President and CEO. \u201cI originally joined ImmuCell in 1989 and am very grateful to have had the opportunity to serve as the President and CEO of this growing Company since 2000.\u201d<\/p>\n<p>Mr. Brigham\u2019s prior additional responsibilities as principal financial officer have been transferred to the Company\u2019s recently hired Chief Financial Officer, Timothy C. Fiori. The Board of Directors\u2019 search process for a new CEO is already underway with the expectation that Mr. Brigham would be available to help transition his CEO responsibilities as well.<\/p>\n<p>\u201cWhile there is no set deadline, our goal is to identify and select a top-notch candidate by around year-end, and I am fully committed to the search for a new leader,\u201d continued Mr. Brigham. \u201cI plan to remain until we find the optimal candidate, and I look forward to serving on our Board of Directors through my just elected term ending in June of 2026 and to continued Board service after that, subject to the vote of stockholders.\u201d<\/p>\n<p>\n        <strong><br \/>\n          <u>About ImmuCell:<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>ImmuCell Corporation (<strong>Nasdaq: ICCC<\/strong>) creates scientifically proven and practical products to improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets <strong>First Defense<\/strong><sup>\u00ae<\/sup>, which provides <strong>Immediate Immunity<\/strong>\u2122 to newborn dairy and beef calves, and is developing <strong>Re-Tain<\/strong><sup>\u00ae<\/sup>, a novel treatment for subclinical mastitis in dairy cows without FDA-required milk discard or pre-slaughter withdrawal label restrictions that hamper traditional mastitis antibiotics. Press releases and other information about the Company are available at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hqVdRQNI27PWjf6O93K1H19HzT4RU6yGWkuALKNqGVuBRefBnYEP1z_QCoLHvlol8FPrEDU91EaJbuRRgIsXjf9mr6w7JdBZHyxdjNHFh4k=\" rel=\"nofollow\" target=\"_blank\">http:\/\/www.immucell.com<\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;vertical-align: top\">\n            <strong>Contacts:<\/strong>\n          <\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%;vertical-align: top\">Michael F. Brigham, President and CEO<br \/> Timothy C. Fiori, CFO<br \/>ImmuCell Corporation<br \/> (207) 878-2770<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td style=\"vertical-align: top\">Joe Diaz, Robert Blum and Joe Dorame<br \/> Lytham Partners, LLC<br \/> (602) 889-9700<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<p>\n        <strong><br \/>\n          <u>Cautionary Note Regarding Forward-Looking Statements (Safe<\/u><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <u>Harbor<\/u><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <u>Statement):<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p>This Press Release contains \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and will often include words such as \u201cexpects\u201d, \u201cmay\u201d, \u201canticipates\u201d, \u201caims\u201d, \u201cintends\u201d, \u201cwould\u201d, \u201ccould\u201d, \u201cshould\u201d, \u201cwill\u201d, \u201cplans\u201d, \u201cbelieves\u201d, \u201cestimates\u201d, \u201ctargets\u201d, \u201cprojects\u201d, \u201cforecasts\u201d, \u201cseeks\u201d and similar words and expressions. Such statements include, but are not limited to, any forward-looking statements relating to: our plans, goals and strategies for our business; projections of future operational performance; future demand for our products; the timing and outcome of pending or anticipated applications for regulatory approvals; and any other statements that are not historical facts. Such statements involve known and unknown risks and uncertainties that may cause the Company&#8217;s actual results, financial or operational performance or achievements to be materially different from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjgxYTk2N2QtMzQ0Yy00MTA3LWE2NzQtMDUwNWVmYWJlYzZiLTExMDEzODAtMjAyNS0wNi0yNS1lbg==\/tiny\/ImmuCell-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) &#8212; ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today\u00a0announced that it has commenced a search for a successor in the position of President and CEO. \u201cI turn 65 this fall and have told my fellow Directors that I would like to retire from full-time work by early 2026,\u201d said Michael F. Brigham, President and CEO. \u201cI originally joined ImmuCell in 1989 and am very grateful to have had the opportunity to serve as the President and CEO of this growing Company since 2000.\u201d Mr. Brigham\u2019s prior additional &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ImmuCell Embarks on CEO Succession Planning Process&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-863571","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ImmuCell Embarks on CEO Succession Planning Process - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmuCell Embarks on CEO Succession Planning Process - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) &#8212; ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today\u00a0announced that it has commenced a search for a successor in the position of President and CEO. \u201cI turn 65 this fall and have told my fellow Directors that I would like to retire from full-time work by early 2026,\u201d said Michael F. Brigham, President and CEO. \u201cI originally joined ImmuCell in 1989 and am very grateful to have had the opportunity to serve as the President and CEO of this growing Company since 2000.\u201d Mr. Brigham\u2019s prior additional &hellip; Continue reading &quot;ImmuCell Embarks on CEO Succession Planning Process&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-25T12:44:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ImmuCell Embarks on CEO Succession Planning Process\",\"datePublished\":\"2025-06-25T12:44:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/\"},\"wordCount\":549,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/\",\"name\":\"ImmuCell Embarks on CEO Succession Planning Process - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=\",\"datePublished\":\"2025-06-25T12:44:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-embarks-on-ceo-succession-planning-process\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImmuCell Embarks on CEO Succession Planning Process\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmuCell Embarks on CEO Succession Planning Process - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/","og_locale":"en_US","og_type":"article","og_title":"ImmuCell Embarks on CEO Succession Planning Process - Market Newsdesk","og_description":"PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) &#8212; ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today\u00a0announced that it has commenced a search for a successor in the position of President and CEO. \u201cI turn 65 this fall and have told my fellow Directors that I would like to retire from full-time work by early 2026,\u201d said Michael F. Brigham, President and CEO. \u201cI originally joined ImmuCell in 1989 and am very grateful to have had the opportunity to serve as the President and CEO of this growing Company since 2000.\u201d Mr. Brigham\u2019s prior additional &hellip; Continue reading \"ImmuCell Embarks on CEO Succession Planning Process\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-25T12:44:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ImmuCell Embarks on CEO Succession Planning Process","datePublished":"2025-06-25T12:44:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/"},"wordCount":549,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/","name":"ImmuCell Embarks on CEO Succession Planning Process - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=","datePublished":"2025-06-25T12:44:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NDI4MiM3MDE3MTA1IzIwODk4MDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-embarks-on-ceo-succession-planning-process\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ImmuCell Embarks on CEO Succession Planning Process"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=863571"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863571\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=863571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=863571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=863571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}